Joanne Stringfield Sells 380 Shares of The Pennant Group, Inc. (NASDAQ:PNTG) Stock

The Pennant Group, Inc. (NASDAQ:PNTG) Director Joanne Stringfield sold 380 shares of the business’s stock in a transaction dated Wednesday, October 23rd. The stock was sold at an average price of $33.56, for a total value of $12,752.80. Following the sale, the director now owns 27,805 shares of the company’s stock, valued at $933,135.80. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

The Pennant Group Trading Up 0.7 %

NASDAQ PNTG opened at $33.53 on Friday. The company’s fifty day simple moving average is $33.94 and its 200-day simple moving average is $27.63. The stock has a market cap of $1.01 billion, a P/E ratio of 62.09, a PEG ratio of 3.42 and a beta of 2.01. The Pennant Group, Inc. has a 52 week low of $10.46 and a 52 week high of $37.13. The company has a current ratio of 1.12, a quick ratio of 1.12 and a debt-to-equity ratio of 0.48.

The Pennant Group (NASDAQ:PNTG) last issued its quarterly earnings data on Tuesday, August 6th. The company reported $0.19 EPS for the quarter, topping analysts’ consensus estimates of $0.17 by $0.02. The firm had revenue of $168.75 million for the quarter, compared to analyst estimates of $156.71 million. The Pennant Group had a net margin of 3.16% and a return on equity of 13.74%. Equities research analysts predict that The Pennant Group, Inc. will post 0.75 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research firms have issued reports on PNTG. Oppenheimer boosted their price objective on shares of The Pennant Group from $28.00 to $34.00 and gave the stock an “outperform” rating in a research note on Thursday, August 8th. Truist Financial upped their price target on shares of The Pennant Group from $34.00 to $38.00 and gave the stock a “hold” rating in a research report on Monday, October 7th. Stephens reissued an “overweight” rating and issued a $40.00 price objective on shares of The Pennant Group in a research report on Wednesday, October 9th. Finally, Royal Bank of Canada upped their target price on The Pennant Group from $26.00 to $38.00 and gave the stock an “outperform” rating in a research report on Wednesday.

Institutional Investors Weigh In On The Pennant Group

A number of hedge funds have recently bought and sold shares of the business. 8 Knots Management LLC raised its position in shares of The Pennant Group by 34.0% in the 1st quarter. 8 Knots Management LLC now owns 2,462,553 shares of the company’s stock valued at $48,340,000 after purchasing an additional 625,061 shares in the last quarter. Sei Investments Co. increased its stake in shares of The Pennant Group by 679.7% in the first quarter. Sei Investments Co. now owns 136,026 shares of the company’s stock worth $2,670,000 after buying an additional 118,581 shares during the last quarter. Grandeur Peak Global Advisors LLC acquired a new stake in The Pennant Group in the first quarter valued at $2,225,000. Vanguard Group Inc. boosted its stake in The Pennant Group by 4.3% during the 1st quarter. Vanguard Group Inc. now owns 1,859,679 shares of the company’s stock valued at $36,505,000 after acquiring an additional 77,052 shares during the last quarter. Finally, Federated Hermes Inc. grew its holdings in The Pennant Group by 600.0% during the 2nd quarter. Federated Hermes Inc. now owns 54,045 shares of the company’s stock worth $1,253,000 after acquiring an additional 46,324 shares in the last quarter. Institutional investors and hedge funds own 85.88% of the company’s stock.

The Pennant Group Company Profile

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.